Health Care: Drugs


$41.825 n/a | n/a%
02/12/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 41.83
52 Week High 76.69
52 Week Low 37.59
Avg. Daily Vol. (Mil) 6.62
Beta (3 year) 1.27
Share Related Items
Mkt Cap (Mil) 20,569.78
Shares Out (Mil) 491.75
Float (Mil) 366.34
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.00
Current Ratio 1.80
LT Debt/ Equity 0.60
Total Debt / Equity 0.65
Valuation Ratios
Price Earnings 24.50
Price/Sales 2.18
Price/Book 2.10
Price/Cash Flow 12.10
Per Share Data
Earnings 1.70
Sales 19.18
Book Value 19.96
Cash Flow 3.46
Business Summary
Mylan NV together with its subsidiaries, is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals.
General Information
Building 4, Trident Place
Mosquito Way
Hatfield, AL10 9UL
Industry : Drugs
Sector: Health Care
Employees: 30000
CEO: Heather Bresch
Short Interest
Current Month (Mil) 51.54
Previous Month (Mil) 55.28
Short Interest Ratio (Days) 9.70
Management Effectiveness
Return on Equity 8.60
Return on Assets 4.00
Return on Investments 5.40
Gross Margin 55.20
EBIT Margin 14.60
Profit Margin 9.00

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter